We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$36.3B
AUM Growth
+$2.54B
(+7.5%)
Cap. Flow
+$1.28B
Cap. Flow
% of AUM
3.53%
Top 10 Holdings %
Top 10 Hldgs %
14.85%
Holding
3,030
New
42
Increased
2,539
Reduced
264
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$34.8M |
| 2 |
Apple
AAPL
|
+$33.7M |
| 3 |
ExxonMobil
XOM
|
+$30M |
| 4 |
Microsoft
MSFT
|
+$25.3M |
| 5 |
Fortive
FTV
|
+$24.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$81.1M |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$25.4M |
| 3 |
Danaher
DHR
|
+$24.4M |
| 4 |
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
|
+$20.3M |
| 5 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.71% |
| 2 | Financials | 14.59% |
| 3 | Healthcare | 13.89% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
1701
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.24M | ﹤0.01% |
34,323
+276
| +0.8% | +$5.92K |
|
1702
Interparfums
IPAR
$4B
| $1.24M | ﹤0.01% |
38,308
+1,202
| +3% | +$38.4K |
|
|
WIN
1703
DELISTED
Windstream Holdings Inc
WIN
| $1.23M | ﹤0.01% |
24,485
+160
| +0.7% | +$7.32K |
|
|
MNR
1704
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.23M | ﹤0.01% |
86,194
+2,640
| +3% | +$36.7K |
|
1705
Inogen
INGN
$182M
| $1.23M | ﹤0.01% |
20,504
+1,470
| +8% | +$81.9K |
|
|
SAFE
1706
Safehold
SAFE
$1.16B
| $1.23M | ﹤0.01% |
23,510
+2,787
| +13% | +$142K |
|
|
WSTC
1707
DELISTED
West Corporation
WSTC
| $1.23M | ﹤0.01% |
55,574
+915
| +2% | +$20.5K |
|
|
FOE
1708
DELISTED
Ferro Corporation
FOE
| $1.22M | ﹤0.01% |
88,578
+5,392
| +6% | +$71.2K |
|
|
PTLA
1709
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.22M | ﹤0.01% |
53,641
-350
| -0.6% | -$8.21K |
|
1710
Amkor Technology
AMKR
$12.6B
| $1.22M | ﹤0.01% |
125,189
+1,650
| +1% | +$13.2K |
|
|
ARRY
1711
DELISTED
Array Biopharma Inc
ARRY
| $1.22M | ﹤0.01% |
180,210
-400
| -0.2% | -$1.55K |
|
1712
Federal Signal
FSS
$7.88B
| $1.21M | ﹤0.01% |
91,487
+3,575
| +4% | +$47K |
|
1713
TTM Technologies
TTMI
$12.6B
| $1.21M | ﹤0.01% |
105,833
+9,680
| +10% | +$95.7K |
|
1714
Saia
SAIA
$9.61B
| $1.2M | ﹤0.01% |
40,187
+1,730
| +4% | +$49.6K |
|
1715
McGrath RentCorp
MGRC
$2.92B
| $1.2M | ﹤0.01% |
37,831
+1,986
| +6% | +$62.8K |
|
1716
Virtus Investment Partners
VRTS
$1.13B
| $1.2M | ﹤0.01% |
12,264
-415
| -3% | -$36.4K |
|
|
XXIA
1717
DELISTED
Ixia
XXIA
| $1.2M | ﹤0.01% |
95,879
+4,215
| +5% | +$48.3K |
|
|
DEL
1718
DELISTED
Deltic Timber
DEL
| $1.2M | ﹤0.01% |
17,655
+625
| +4% | +$43.4K |
|
1719
Ethan Allen Interiors
ETD
$598M
| $1.19M | ﹤0.01% |
38,123
+1,765
| +5% | +$59.8K |
|
1720
Upbound Group
UPBD
$1.18B
| $1.19M | ﹤0.01% |
94,166
-18,492
| -16% | -$231K |
|
1721
Pegasystems
PEGA
$5.16B
| $1.19M | ﹤0.01% |
80,514
+1,150
| +1% | +$15.6K |
|
|
TLRD
1722
DELISTED
Tailored Brands, Inc.
TLRD
| $1.18M | ﹤0.01% |
75,232
+2,605
| +4% | +$37.9K |
|
|
ONCE
1723
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.18M | ﹤0.01% |
19,624
+4,108
| +26% | +$237K |
|
1724
MiMedx Group
MDXG
$622M
| $1.17M | ﹤0.01% |
136,284
+4,095
| +3% | +$32.4K |
|
|
UHT
1725
Universal Health Realty Income Trust
UHT
$592M
| $1.17M | ﹤0.01% |
18,557
+1,194
| +7% | +$72K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2016 Portfolio in Review
As of Q3 2016, RhumbLine Advisers held 3,030 positions worth $36.3B, up 7.5% from $33.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.28B of net new capital in Q3 2016, opening 42 new positions and adding to 2,539 existing holdings. Its largest new stake was Fortive: 753,372 shares worth $24.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Danaher, an estimated $24.4M trimmed.
- RhumbLine Advisers's largest Q3 2016 buy was Fortive: 753,372 shares worth $24.2M.
- RhumbLine Advisers added most to Charter Communications in Q3 2016, an estimated $34.8M increase.
- RhumbLine Advisers's biggest Q3 2016 reduction was Danaher, cutting an estimated $24.4M.
- RhumbLine Advisers fully exited EMC CORPORATION in Q3 2016, selling an estimated $81.1M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $36.3B portfolio in Q3 2016.
- RhumbLine Advisers opened 42 new positions and closed 157 in Q3 2016.
- RhumbLine Advisers's portfolio value rose 7.5% quarter-over-quarter to $36.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2016, filed 8 Nov 2016.